发明名称 FAST DISSOLVING ORALLY CONSUMABLE FILM CONTAINING PHARMACEUTICALLY ACTIVE AGENT
摘要 <P>PROBLEM TO BE SOLVED: To provide a fast dissolving orally consumable film containing a pharmaceutically active agent, more particularly to films containing an oily pharmaceutically active agent. <P>SOLUTION: There are provided a method, composition, medication, and schedule of administration for treating autoimmune diseases including systemic lupus erythematosus (SLE), which includes administration of a TACI-Ig fusion molecule such as Atacicept, etc., to a patient in need of such treatment. One embodiment relates to the use of the TACI-Ig fusion molecule administering a sufficient amount which retards, suppresses or inhibits the functions inducing proliferation of BLyS and APRIL, in particular relates to the use of the fusion molecule in a plurality of administration in a relatively small amount of administration through the whole treating process. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2010138198(A) 申请公布日期 2010.06.24
申请号 JP20100053758 申请日期 2010.03.10
申请人 WARNER-LAMBERT CO LLC 发明人 KULKARNI NEEMA MAHESH;KUMAR LORI DEE;SORG ALBERT FRANK
分类号 A61K9/70;A61K8/02;A61K8/21;A61K8/34;A61K8/37;A61K8/41;A61K8/43;A61K8/44;A61K8/49;A61K8/64;A61K8/65;A61K8/73;A61K8/81;A61K8/86;A61K8/92;A61K9/00;A61K9/14;A61K9/20;A61K9/28;A61K31/00;A61K31/045;A61K31/30;A61K31/405;A61K31/415;A61K31/42;A61K31/44;A61K31/485;A61K31/60;A61K31/7012;A61K31/715;A61K38/38;A61K47/00;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/42;A61M37/00;A61P11/14;A61Q11/00 主分类号 A61K9/70
代理机构 代理人
主权项
地址